Soleno Therapeutics to Participate in Upcoming November Conferences

Soleno Therapeutics (NASDAQ: SLNO) announced participation in three investor conferences in November 2025 with dates, times, formats, and webcast availability.

Rhea-AI Summary

Soleno Therapeutics (NASDAQ: SLNO) announced participation in three investor conferences in November 2025 with dates, times, formats, and webcast availability.

Events: Guggenheim Securities Healthcare Innovation Conference on Nov 11, 2025 at 9:00 AM ET (fireside chat); Stifel 2025 Healthcare Conference on Nov 12, 2025 at 8:40 AM ET (fireside chat); and Jefferies London Healthcare Conference on Nov 18, 2025 at 5:00 PM GMT (presentation). Replays will be posted in the investor section at www.soleno.life.

Argus Oct 28 session

+1.70% close to close Open Argus

Details

News Market Reaction – SLNO

On Oct 28, the day this news came out, SLNO closed 1.70% above the previous close.

Data tracked by StockTitan Argus for the Oct 28 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in November:

Guggenheim Securities Healthcare Innovation Conference
Presentation Date: Tuesday, November 11, 2025 at 9:00 AM ET
Presentation Format: Fireside Chat
Webcast: Here

Stifel 2025 Healthcare Conference
Presentation Date: Wednesday, November 12, 2025 at 8:40 AM ET
Presentation Format: Fireside Chat
Webcast: Here

Jefferies London Healthcare Conference
Presentation Date: Tuesday, November 18, 2025 at 5:00 PM GMT
Presentation Format: Presentation
Webcast: Here

Replays of the events will be available in the Investors section on the Company’s website at www.soleno.life.

About Soleno Therapeutics, Inc.

Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s first commercial product, VYKAT XR™ (diazoxide choline) extended-release tablets, formerly known as DCCR, is a once-daily oral treatment for hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome. For more information, please visit www.soleno.life.

Corporate Contact:
Brian Ritchie
LifeSci Advisors, LLC
212-915-2578

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Soleno Therapeutics (SLNO) present at the Guggenheim Securities Healthcare Innovation Conference?

Soleno will present on Tuesday, November 11, 2025 at 9:00 AM ET as a fireside chat; a webcast link is provided for the event.

What is the date and format for Soleno Therapeutics (SLNO) at the Stifel 2025 Healthcare Conference?

Soleno is scheduled for Wednesday, November 12, 2025 at 8:40 AM ET in a fireside chat format with an available webcast.

When and how will Soleno Therapeutics (SLNO) present at the Jefferies London Healthcare Conference?

Soleno will present on Tuesday, November 18, 2025 at 5:00 PM GMT in a presentation format with a webcast link.

Where can investors watch replays of Soleno Therapeutics (SLNO) November 2025 conference presentations?

Replays will be available in the Investors section on the company website at www.soleno.life.

Are the Soleno Therapeutics (SLNO) November 2025 presentations live-streamed?

Yes, each listed event includes a webcast link for live access and a replay will be posted afterward.

Which investor conferences will Soleno Therapeutics (SLNO) attend in November 2025?

Soleno will attend Guggenheim Securities Healthcare Innovation (Nov 11), Stifel 2025 Healthcare (Nov 12), and Jefferies London Healthcare (Nov 18) in November 2025.